Visioneering Technologies, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VTI.AX research report →
Price Chart
About the company
Visioneering Technologies, Inc. is a medical device company focused on the development, production, marketing, and distribution of contact lenses. Its commercial activities extend across North America, Europe, and the Asia-Pacific regions.
- CEO
- Juan Carlos Aragon
- IPO
- 2017
- HQ
- Alpharetta, GA, US
Get TickerSpark's AI analysis on VTI.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.70M
- P/E
- -0.32
- PEG
- -0.01
- P/S
- 0.31
- P/B
- 0.29
- EV/EBITDA
- 0.01
- Div Yield
- 0.00%
- Gross Margin
- 54.90%
- Op Margin
- -67.52%
- Net Margin
- -39.80%
- ROE
- -57.27%
- ROIC
- -112.77%
Latest fiscal year · YoY change
- Revenue
- $8.67M+19.0%
- Gross Profit
- $4.76M+43.5%
- Op Income
- $-5,854,128
- Net Income
- $-3,451,000+41.0%
- EPS
- $-0.15+31.8%
- OCF Growth
- +7.0%
- FCF Growth
- +38.3%
- 52W High
- $0.25
- 52W Low
- $0.04
- 50D MA
- $0.06
- 200D MA
- $0.11
- Beta
- 1.87
- RSI (14)
- 48
- Avg Volume
- 146.23K
No earnings-call transcripts are available for VTI.AX yet.
- Free Float
- 69.0%
- Shares Outstanding
- 56.13M
- Float Shares
- 38.75M
Our VTI.AX coverage
Recent articles, reports, and earnings notes.
No research on VTI.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VTI.AX report →